Demonstrated ability to establish and implement scientific strategies for biologic drug R&D. Successfully built and managed biotherapeutic R&D team of diversified group of scientists Led multidisciplinary teams to deliver preclinical development candidates(Ab and mRNA drug) A strong and passionate leader and mentor with excellent communication skills Strategic planning and novel drug discovery technology platform development Managed CROs as well as external collaborations Co-authored many peer-reviewed journal/book publications and patents Specialties: Protein replacement therapy, ERT to treat LSD and other genetic diseases Protein therapeutics for rare genetic diseases/Orphan drug development Therapeutic protein engineering, optimization and characterization. Metabolic/genetic diseases, and inflamattion/autoimmune diseases PoC and preclinical IND enabling studies Biomarker and translational medicine Protein/antibody/mRNA engineering and optimization/bispecific intrabody CHO cell line development, upstream/downstream process development Bioanalytical and bioassay development stem cell culture and transgenesis
Zhinan Xia is a highly experienced professional with 26.8 years of work experience in the field of protein chemistry, cell purification, biotechnology, and antibodies. Based in the United States, Zhinan has successfully established and implemented scientific strategies for biologic drug R&D. He has successfully built and managed biotherapeutic R&D teams and led multidisciplinary teams to deliver preclinical development candidates. Zhinan is a strong leader and mentor with excellent communication skills. He has a proven track record of strategic planning, drug discovery technology platform development, and managed CROs and external collaborations.
At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using mRNA as a drug are significant and far-reaching and could meaningfully improve how medicines are discovered, developed and manufactured. To learn more, visit www.modernatx.com. This Moderna page is not the appropriate place to report adverse events (side-effects) for any products. If you are or someone you know is experiencing a side effect, please reach out to your healthcare professional. Moderna is continuously monitoring the safety of its products. We encourage you to report any side effects directly to us at 1‑866‑MODERNA (1‑866‑663‑3762)
MassBio, a not-for-profit organization that represents and provides services and support for the Massachusetts life sciences industry, is the nation's oldest biotechnology trade association. Founded in 1985, MassBio is committed to advancing Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system and improve patient lives. Representing more than 1000 biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and healthcare, MassBio works to advance policy and promote education, while providing member programs and events, industry information, and services.
Synageva BioPharma is a biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines for people living with rare diseases of high unmet medical need. We are passionate about our commitment to improving their lives and those of their families for generations to come. Our experienced team has helped bring several life-saving therapies for diseases that were once considered too rare for development treatments. We believe that every patient deserves treatment options, no matter how rare their disease. We believe that when it comes to delivering innovative therapies, Every Second Counts.
Breakthroughs That Change Patients' Lives: Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend and significantly improve lives. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.To learn more, visit www.pfizer.com. For additional information on our guidelines, please visit http://www.pfizer.com/community-guidelines Beware of scams from individuals, organizations and Internet sites claiming to represent Pfizer in recruitment activities. A formal Pfizer recruitment process is required for all authorized positions posted by Pfizer prior to issuing an offer of employment. This Pfizer process includes an interview and never requires payment or fees from job applicants. If you receive a suspicious email message or phone call about recruiting on behalf of Pfizer, do not provide any personal information or pay any fees. Interested candidates should apply to current openings through this Pfizer website. Pfizer accepts no responsibility for any costs or charges incurred as a result of fraudulent activity.
Dana-Farber Cancer Institute is committed to providing expert, compassionate care to children and adults with cancer, while advancing the understanding, treatment, cure, and prevention of cancer and related diseases.
High Throughput Screening
We found 2 Zhinan Xia's email addresses
We found 2 Zhinan Xia's phone numbers
Zhinan Xia works for DynamiCure Biotechnology
Zhinan Xia's role in DynamiCure Biotechnology is Chief Strategy Officer
Zhinan Xia works in the industry of
Zhinan Xia's colleagues are
Zhinan Xia's latest job experience is Chief Strategy Officer at DynamiCure Biotechnology
Zhinan Xia's latest education in Harvard Medical School